Taxpayer Biolabs EXPOSED — 120+ Worldwide

US Treasury Department building with statue and flag.

Declassified records show U.S. taxpayer money backed more than 120 foreign biolabs, reviving a fight over secrecy, safety, and who misled the public.

Story Highlights

Director of National Intelligence Tulsi Gabbard released records on U.S.-funded biolabs in 30+ countries ^[2]^[3].
The release ties to President Trump’s order to end federal funding of dangerous gain-of-function research ^[3].
The files point to labs handling high-risk pathogens like anthrax, Ebola, and SARS, raising safety questions ^[1]^[3].
Officials still say the documents do not prove bioweapons programs; transparency gaps remain ^[3]^[6].

What The Declassified Records Say About U.S.-Funded Foreign Biolabs

Director of National Intelligence Tulsi Gabbard announced a declassification that details U.S. support for more than 120 biolabs across over 30 countries. Her office said the intelligence community will map where the labs are, which pathogens they hold, and what research took place. Gabbard argued this release corrects years of misleading claims from former officials. She said politicians denied these ties while taxpayers funded them abroad. The records put specific locations and programs on the public radar ^[2]^[3].

Gabbard stated many of these facilities handled dangerous agents, including anthrax, Ebola, and severe acute respiratory syndrome. That point matters for safety, oversight, and cross-border risks. The materials describe a wide network beyond Ukraine, suggesting a long-running program rather than a one-off project. The scope raises basic questions: who approved the money, what safety standards applied, and how well Congress tracked results. These are practical, verifiable issues that demand follow-up ^[1]^[3].

How Trump’s Policy Shift Shapes The Next Steps

The release links directly to President Trump’s directive to end federal funding of dangerous gain-of-function research worldwide. Gabbard’s office said the intelligence community will work with other agencies to identify labs, pathogens, and research lines to enforce that policy. This frames the issue as a compliance and accountability push. It aims to stop risky work that could raise pandemic threats. That effort depends on full records, clear definitions, and firm oversight to hold agencies to the new standard ^[3].

The Trump policy gives Congress and inspectors a clear mandate. Lawmakers can now demand contracts, grant files, and inventory logs for each site. Auditors can compare activities against U.S. rules in place at the time. If work crossed the line, they can document it, fix gaps, and end funding. If work stayed within public-health lanes, they can say so with proof. Either way, transparency beats rumor. The White House priority is to close risk while keeping real biodefense intact ^[3].

What The Records Do Not Prove, And Why It Matters

The public documents do not prove bioweapons programs. They describe funding ties, pathogen handling, and oversight concerns. They do not show named experiments, principal investigators, or protocols that meet a defined gain-of-function threshold. The release also lacks a full, indexed set of declassified files for easy review. That gap limits verification by outside experts. These limits argue for posting underlying contracts, inventories, and safety reports for each lab ^[3]^[6].

No, the comment speculates without evidence. Tulsi Gabbard is outgoing DNI, resigning effective June 30 for her husband’s health. On June 12 she released declassified slides on 120+ US-funded biolabs across 30+ countries, framing it as exposing prior cover-ups and GoF risks tied…

— Grok (@grok) June 14, 2026

The debate is already fierce because past claims were tagged as disinformation. That history can cloud fair review of real records. The right answer is sunlight with receipts. Post document titles, dates, redactions, and chain of custody. Publish site-level pathogen lists and biosafety approvals. Take sworn testimony from program managers and host-nation officials. These steps let Americans judge what was public health, what was dual-use, and what never should have been funded in the first place ^[6].

Why This Matters For Security, Budgets, And American Trust

American families paid for foreign labs that handled high-risk germs. They deserve to know the safety rules, the guardrails, and the results. Clear facts help stop mission creep, end waste, and protect our borders from lab leaks abroad. The intelligence community says it will map labs, pathogens, and research lines. That task must lead to a full public record, firm controls, and a funding cutoff for anything that violates U.S. law or common sense. Trust requires proof, not spin ^[2]^[3].